Početna stranicaCHJTF • OTCMKTS
add
CSPC Pharmaceutical Group Ltd
0,96 $
Prije radnog vremena:(16,70 %)−0,16
0,80 $
Zatvoreno: 18. lis, 08:05:00 GMT -4 · USD · OTCMKTS · Odricanje od odgovornosti
Preth. zaklj. cijena
0,96 $
Godišnji raspon
0,54 $ - 0,96 $
Tržišna kapitalizacija
76,84 mlr. HKD
Prosječna količina
2,34 tis.
P/E omjer
-
Prinos dividende
-
Glavno tržište vrijednosnica
HKG
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (CNY) | lip 2024.info | Godišnja promjena |
|---|---|---|
Prihod | 7,30 mlr. | −9,04 % |
Operativni troškovi | 3,49 mlr. | −12,37 % |
Neto dohodak | 1,41 mlr. | −8,49 % |
Neto profitabilnost | 19,28 | 0,63 % |
Zarada po dionici | — | — |
EBITDA | 1,94 mlr. | −0,82 % |
Efektivna porezna stopa | 18,44 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (CNY) | lip 2024.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 10,82 mlr. | −15,16 % |
Ukupna imovina | 47,90 mlr. | 9,67 % |
Ukupne obveze | 11,42 mlr. | 12,43 % |
Ukupni kapital | 36,47 mlr. | — |
Dionice u optjecaju | 11,83 mlr. | — |
Cijena prema knjigovodstvenoj vrijednosti | 0,33 | — |
Povrat imovine | — | — |
Povrat kapitala | 11,49 % | — |
Tok novca
Neto promjena novca
| (CNY) | lip 2024.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 1,41 mlr. | −8,49 % |
Gotovina od poslovanja | — | — |
Gotovina iz ulaganja | — | — |
Gotovina iz financiranja | — | — |
Neto promjena novca | — | — |
Slobodan tok novca | — | — |
Više
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province.
CSPC produces both active pharmaceutical ingredient and formulations. API products include
penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products.
CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP.
CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises.
One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion.
CSPC Pharma is recognized as one of China's “500 Most Valuable Chinese Brands” and “Top 500 Chinese Enterprises.” Wikipedia
Glavni izvršni direktor
Osnovano
1992
Web-lokacija
Zaposlenici
20.300
